2022
DOI: 10.1039/d2tb00973k
|View full text |Cite
|
Sign up to set email alerts
|

Targeted intelligent mesoporous polydopamine nanosystems for multimodal synergistic tumor treatment

Abstract: In this work, we obtained targeted smart mesoporous polydopamine delivery systems (PPMD@GA/si) for gene-mediated photochemotherapy of tumors through a combinatorial strategy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 47 publications
(55 reference statements)
0
2
0
Order By: Relevance
“…Glycosides are well-known to exhibit important pharmacological activities. 2 3 4 Pertinent examples include inhibitors of various glycoproteins, 5 glycosides with anticarcinogenic activities, 6 novel glycosidic flavonoids acting as antioxidant and antibiotic agents, 7 compounds that regulate body fluid, etc. 8…”
Section: Introductionmentioning
confidence: 99%
“…Glycosides are well-known to exhibit important pharmacological activities. 2 3 4 Pertinent examples include inhibitors of various glycoproteins, 5 glycosides with anticarcinogenic activities, 6 novel glycosidic flavonoids acting as antioxidant and antibiotic agents, 7 compounds that regulate body fluid, etc. 8…”
Section: Introductionmentioning
confidence: 99%
“…Such as the small interfering Ribonucleic acid (siRNA), which has great promising in the treatment of cancer and viral infectious diseases, has poor stability in biological media and their inability to diffuse across cell membranes are huge obstacles to developing siRNA-based therapies ( Zandanel et al, 2020 ). Yang et al (2022a) established an intelligent nanoparticle delivery system by curing the mesoporous-mesoporous polydopamine (MPDA) and gambogic acid (GA), and siRNA with PCMs together. PCMs can effectively avoid siRNA inactivation and accidental release of GA has targeted accumulation at the tumor site.…”
Section: Introductionmentioning
confidence: 99%